Sanofi is an innovative global healthcare company driven by one purpose: to chase the miracles of science to improve people’s lives. Throughout the world, its teams are dedicated to transforming the practice of medicine by working to turn the impossible into the possible. Sanofi provides potentially life-changing treatment options and life-saving vaccine protection to millions of people globally while putting sustainability and social responsibility at the center of its ambitions.
Sanofi recently acquired Translate Bio, a clinical-stage mRNA therapeutics company. This was a big change for the legacy Translate employees as they were integrated into Sanofi’s infrastructure. Greg Troiano, Chief Manufacturing Officer of the mRNA Center of Excellence, wanted to ensure his team was set up for success as it merged with Sanofi’s.
Greg wanted to be proactive and head off any potential problems for his team. Having been through large organizational changes in the past, Greg knew he had to ensure his team had clarity through the turbulence.
Greg said, “We were moving from the world of a very small team to one that is global. We were taking half of Translate and half of Sanofi’s existing resources and forming a new center of excellence. We had to create an organization that was more scalable.”
Greg found Better Organizations by Design (BOxD) and was impressed right away. Greg said, “They listen to the existing organization and are collaborative in terms of getting input from across the team.”